Page last updated: 2024-11-05

thalidomide and Hyperidrosis

thalidomide has been researched along with Hyperidrosis in 3 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deaner, P1
Deaner, PB1
Smithells, RW1

Other Studies

3 other studies available for thalidomide and Hyperidrosis

ArticleYear
Thalidomide for distressing night sweats in advanced malignant disease.
    Palliative medicine, 1998, Volume: 12, Issue:3

    Topics: Fever; Humans; Hyperhidrosis; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Thalidomide

1998
The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report.
    Palliative medicine, 2000, Volume: 14, Issue:5

    Topics: Adult; Aged; Female; Humans; Hyperhidrosis; Male; Middle Aged; Neoplasms; Quality of Life; Terminal

2000
Thalidomide, absent appendix, and sweating.
    Lancet (London, England), 1978, May-13, Volume: 1, Issue:8072

    Topics: Appendix; Child; Female; Humans; Hyperhidrosis; Thalidomide

1978